{"status":"success","data":{"title":"Neutropenic Fever and Cancer","slug":"cancer-neutropenic-fever","tags":["ciprofloxacin","vancomycin","cefipime","pipercillin-tazobactam","amoxicillin-clavulanate","aztreonam"],"collection":["Hematology and Oncology"],"content":"<h1 id=\"neutropenic-fever-and-cancer\">Neutropenic Fever and Cancer</h1>\n<p>Chemotherapy causes neutropenia in 10-50% of patients with solid tumors and &gt; 80% of patients with hematologic malignancies during chemotherapy cycle</p>\n<p><strong>Fever:</strong> ≥ 38.3 C (101 F) or ≥ 38.0 C (100.4 F) over 1-hour period</p>\n<p><strong>Neutropenia:</strong> Absolute neutrophil count &lt; 500 cells/mm3</p>\n<h2 id=\"mascc-score\">MASCC score</h2>\n<p><strong>Multinational Association for Supportive Care in Cancer (MASCC) Score:</strong></p>\n<table>\n<thead>\n<tr>\n<th></th>\n<th></th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td><strong>Burden of febrile neutropenia</strong></td>\n<td>5 pts (mild), 3 pts (moderate)</td>\n</tr>\n<tr>\n<td><strong>No hypotension (SBP ≥ 90 mmHg)</strong></td>\n<td>5 pts</td>\n</tr>\n<tr>\n<td><strong>No COPD</strong></td>\n<td>4 pts</td>\n</tr>\n<tr>\n<td><strong>Solid tumor or hematologic malignancy <span class=\"drug\">with</span> no previous fungal infection</strong></td>\n<td>4 pts</td>\n</tr>\n<tr>\n<td><strong>No dehydration requiring parenteral fluids</strong></td>\n<td>3 pts</td>\n</tr>\n<tr>\n<td><strong>Outpatient status</strong></td>\n<td>3 pts</td>\n</tr>\n<tr>\n<td><strong>Age &lt; 60 years</strong></td>\n<td>2 pts</td>\n</tr>\n</tbody>\n</table>\n<p><strong>HIGH RISK PATIENTS</strong> (require admission):</p>\n<ul>\n<li>MASCC score &lt; 21 <strong>OR</strong></li>\n<li>Any of clinical findings:<ul>\n<li>Prolonged (&gt; 7 days duration) and profound neutropenia (ANC ≤ 100 cells/mm3)</li>\n<li>Hypotension</li>\n<li>Pneumonia</li>\n<li>New abdominal pain</li>\n<li>Neurologic changes</li>\n</ul>\n</li>\n</ul>\n<p><strong>LOW RISK PATIENTS</strong> (may be eligible for outpatient tx):</p>\n<ul>\n<li>MASCC score ≥ 21</li>\n<li>Brief (≤ 7 days duration) neutropenic periods and few co-morbidities</li>\n</ul>\n<h2 id=\"workup\">Workup</h2>\n<ul>\n<li>CBC, BUN/Creatinine, electrolytes, AST/ALT, bilirubin</li>\n<li>Chest xray, if respiratory signs or symptoms</li>\n<li>2 Blood Cx (1 central line lumen if present + 1 peripheral vein, or 2 peripheral veins)</li>\n</ul>\n<h2 id=\"antibiotic-treatment\">Antibiotic Treatment</h2>\n<p><em>Monotherapy:</em> Antipseudomonal beta-lactam (eg. <strong><span class=\"drug\">cefipime</span>, <span class=\"drug\">carbapenem</span>, <span class=\"drug\">pip-tazo</span></strong>)\n<strong><span class=\"drug\">Vancomycin</span></strong>is not always indicated in cancer patients with a neutropenic fever.</p>\n<ul>\n<li>Add <strong>vancomycin</strong> only if suspect catheter-related infection, skin/soft tissue infection, pneumonia, hemodynamic instability, colonization with MRSA/VRE/PCN-resistant <em>Strep pneumoniae</em></li>\n</ul>\n<p><em>For PCN allergy</em>: <strong><span class=\"drug\">Ciprofloxacin</span> + <span class=\"drug\">clindamycin</span>,</strong> or <strong><span class=\"drug\">aztremonam</span> + <span class=\"drug\">vancomycin</span></strong>\n<em>For PO outpatient</em>: <strong><span class=\"drug\">Ciprofloxacin</span> + <span class=\"drug\">amoxicillin-clavulanate</span> </strong></p>\n<h2 id=\"central-line-associated-blood-stream-infection-clabsi-\">Central line-associated blood stream infection (CLABSI)</h2>\n<p><strong>Remove catheter:</strong> Consider removal if any of following: </p>\n<ul>\n<li>Caused by <em>S. aureus</em>, <em>P. aeruginosa</em>, fungi, mycobacteria</li>\n<li>Tunnel infection</li>\n<li>Pocket site infection</li>\n<li>Septic thrombosis</li>\n<li>Endocarditis</li>\n<li>Sepsis with hemodynamic instability</li>\n<li>Bacteremia despite ≥ 72 hours antibiotics</li>\n</ul>\n<p><strong>Keep catheter</strong> and treat with abx: If coag-negative staph</p>\n<h2 id=\"example\">Example</h2>\n<p>A 65 y/o man with a history of prostate cancer presents to your ED from home appearing fairly well and a mild cough for 3 days. He has otherwise no past medical problems. His vital signs are:</p>\n<ul>\n<li>Temperature 39 C</li>\n<li>BP 160/80</li>\n<li>HR 60</li>\n<li>RR 14</li>\n<li>Oxygen saturation 99% on room air</li>\n</ul>\n<p>His absolute neutrophil count (ANC) comes back at 300 cells/mm3. His chest xray shows a right middle lobe pneumonia and a central line catheter tip ending in the SVC.</p>\n<p><strong>Questions:</strong></p>\n<ul>\n<li>Is this a patient &quot;high&quot; or &quot;low&quot; risk per the Multinational Association for Supportive Care in Cancer (MASCC)? (<span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2472d35d3ae92e001575\">View answer</span>)</li>\n<li>Does this person require inpatient admission? (<span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2472d35d3ae92e001576\">View answer</span>)</li>\n<li>What antibiotics would you start on this patient? (<span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2472d35d3ae92e001577\">View answer</span>)</li>\n</ul>\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21205990\">Fairefield AG et. al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. 2010 update by the IDSA. Clinical Infectious Disease 2011; 52 (4): e56-93.</a></li>\n</ul>\n"}}